Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-467759
Filing Date
2012-11-13
Accepted
2012-11-13 17:18:05
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398032d10q.htm 10-Q 851186
2 EX-31.1 d398032dex311.htm EX-31.1 6221
3 EX-31.2 d398032dex312.htm EX-31.2 6227
4 EX-32.1 d398032dex321.htm EX-32.1 5813
  Complete submission text file 0001193125-12-467759.txt   4584880

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20120930.xml EX-101.INS 520629
6 XBRL TAXONOMY EXTENSION SCHEMA abio-20120930.xsd EX-101.SCH 40256
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20120930_cal.xml EX-101.CAL 49443
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20120930_def.xml EX-101.DEF 120852
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20120930_lab.xml EX-101.LAB 316041
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20120930_pre.xml EX-101.PRE 225701
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 121199860
SIC: 2835 In Vitro & In Vivo Diagnostic Substances